504
Views
89
CrossRef citations to date
0
Altmetric
Review

CNS pharmacokinetics of antifungal agents

&
Pages 573-581 | Published online: 19 Oct 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Louise Kelly, Jennifer Walsh, Mairead Skally, Binu Dinesh, Karen Burns, Karina O'Connell, Stephen MacNally, Hilary Humphreys & Fidelma Fitzpatrick. (2023) Candida meningitis/ventriculitis over a decade. Increased morbidity and length of stay a concern. British Journal of Neurosurgery 37:2, pages 227-230.
Read now
Katharine E Stott & William Hope. (2018) Pharmacokinetics–pharmacodynamics of antifungal agents in the central nervous system. Expert Opinion on Drug Metabolism & Toxicology 14:8, pages 803-815.
Read now
Jacob Bodilsen, Matthijs C. Brouwer, Henrik Nielsen & Diederik Van De Beek. (2018) Anti-infective treatment of brain abscess. Expert Review of Anti-infective Therapy 16:7, pages 565-578.
Read now
Darren Michael Moss, Catia Marzolini, Rajith KR Rajoli & Marco Siccardi. (2015) Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies. Expert Opinion on Drug Metabolism & Toxicology 11:8, pages 1203-1217.
Read now
Eline W Muilwijk, Vincent JC Lempers, David M Burger, Adilia Warris, Peter Pickkers, Rob E Aarnoutse & Roger JM Brüggemann. (2015) Impact of special patient populations on the pharmacokinetics of echinocandins. Expert Review of Anti-infective Therapy 13:6, pages 799-815.
Read now
Wei Meng Lim, Paruvathanahalli Siddalingam Rajinikanth, Chitneni Mallikarjun & Yew Beng Kang. (2014) Formulation and delivery of itraconazole to the brain using a nanolipid carrier system. International Journal of Nanomedicine 9, pages 2117-2126.
Read now
Leonardo Andrade-Silva, Kennio Ferreira-Paim, Delio Jose Mora, Paulo Roberto Da Silva, Anderson Assunção Andrade, Natalia Evelyn Araujo, André Luiz Pedrosa & Mario León Silva-Vergara. (2013) Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil. Medical Mycology 51:6, pages 635-640.
Read now
David Andes. (2013) Optimizing antifungal choice and administration. Current Medical Research and Opinion 29:sup4, pages 13-18.
Read now
John R. Perfect & David Andes. (2013) Antifungal therapy: current concepts and evidence-based management. Current Medical Research and Opinion 29:3, pages 289-290.
Read now
Effie L Kuti & Joseph L Kuti. (2010) Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections. Expert Opinion on Drug Metabolism & Toxicology 6:10, pages 1287-1300.
Read now

Articles from other publishers (79)

Fernanda Wirth, Keli J Staudt, Bibiana V Araújo & Kelly Ishida. (2022) Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment. Future Microbiology 17:12, pages 969-982.
Crossref
Sally Galal, Celine Jones & Kevin Coward. 2022. Long-Acting Drug Delivery Systems. Long-Acting Drug Delivery Systems 163 202 .
Koteswara R Chintalacharuvu, Zlatko A Matolek, Benny Pacheco, Erick M Carriera & David O Beenhouwer. (2021) Complexing amphotericin B with gold nanoparticles improves fungal clearance from the brains of mice infected with Cryptococcal neoformans. Medical Mycology 59:11, pages 1085-1091.
Crossref
Caitlin Keighley, Louise Cooley, Arthur J. Morris, David Ritchie, Julia E. Clark, Peter Boan, Leon J. Worth, Monica A. Slavin, Karin A. Thursky, Jason A. Roberts, Leon J. Worth, Christina C. Chang, Sharon C‐A Chen, C. Orla Morrissey, Christopher C. Blyth & Anna Khanina. (2021) Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Internal Medicine Journal 51:S7, pages 89-117.
Crossref
Maggie M. Chau, Kathryn Daveson, Jan‐Willem C. Alffenaar, Amanda Gwee, Su Ann Ho, Deborah J. E. Marriott, Jason A. Trubiano, Jessie Zhao, Jason A. Roberts, Monica A. Slavin, Karin A. Thursky, Jason A. Roberts, Leon J. Worth, Christina C. Chang, Sharon C‐A Chen, C. Orla Morrissey, Christopher C. Blyth & Anna Khanina. (2021) Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021. Internal Medicine Journal 51:S7, pages 37-66.
Crossref
Liuhan Dong, Nan Bai, Tianlin Wang & Yun Cai. (2021) Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of voriconazole in human cerebrospinal fluid. Analytical Methods 13:39, pages 4585-4593.
Crossref
Alba Ruiz-Gaitán & José Luis del Pozo. (2021) AmBisome, tres retos: infección por Candida auris, infección del sistema nervioso central e infección asociada a biopelículas. Revista Iberoamericana de Micología 38:2, pages 84-90.
Crossref
V. N. Zimina & I. B. Viktorova. (2021) Delamanid is a new anti-tuberculosis drug: use, limitations, and prospects. Tuberculosis and Lung Diseases 99:2, pages 58-66.
Crossref
Kelly Ishida & Vinícius de Morais Barroso. 2021. Encyclopedia of Mycology. Encyclopedia of Mycology 449 455 .
Eric A Meyerowitz, Sarimer Sanchez, Michael K Mansour, Virginia A Triant & Marcia B Goldberg. (2020) Isolated Cerebral Mucormycosis in Immunocompetent Adults who Inject Drugs: Case Reports and Systematic Review of the Literature. Open Forum Infectious Diseases 7:12.
Crossref
Erin K McCreary, Karin E Byers, Carolyn Fernandes, Ellen G Kline, David P Nicolau & Ryan K Shields. (2020) Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant Pseudomonas aeruginosa Meningitis . Open Forum Infectious Diseases 7:12.
Crossref
Fernanda Wirth & Kelly Ishida. (2020) Antifungal drugs: An updated review of central nervous system pharmacokinetics. Mycoses 63:10, pages 1047-1059.
Crossref
Cristina de Castro Spadari, Fernanda Wirth, Luciana Biagini Lopes & Kelly Ishida. (2020) New Approaches for Cryptococcosis Treatment. Microorganisms 8:4, pages 613.
Crossref
Mantao Chen, Chongchao Chen, Qing Yang & Renya Zhan. (2020) Candida meningitis in neurosurgical patients: a single-institute study of nine cases over 7 years . Epidemiology and Infection 148.
Crossref
Da Shi, Kirti Kandhwal Chahal, Patricia Oto, Louis-Felix Nothias, Anjan Debnath, James H. McKerrow, Larissa M. Podust & Ruben Abagyan. (2019) Identification of Four Amoebicidal Nontoxic Compounds by a Molecular Docking Screen of Naegleria fowleri Sterol Δ8−Δ7-Isomerase and Phenotypic Assays . ACS Infectious Diseases 5:12, pages 2029-2038.
Crossref
Samuel D. Chorlton. (2019) Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis. Medical Hypotheses 133, pages 109376.
Crossref
Elizabeth Dodds Ashley. (2019) Antifungal Drugs: Special Problems Treating Central Nervous System Infections. Journal of Fungi 5:4, pages 97.
Crossref
Dylan Ryan, William C. Lippert, Alexander J. Fenwick, Mahesh Bhatt & Charles R. Jones. (2019) Central Nervous System Blastomycosis With Multiple Brain Abscesses Presenting as Right Upper Extremity Weakness. The Neurohospitalist 9:4, pages 230-234.
Crossref
Lijun Xu, Ran Tao, Jingjing Wu, Xiahong Dai, Caiqin Hu, Ying Huang, YaoKai Chen, Biao Zhu & Jianqin He. (2019) Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole. Frontiers in Microbiology 10.
Crossref
Sara Longo, Shanti Esmieu, Alice Pastorello, Katie Waine, Kerstin Baiker & Giunio Bruto Cherubini. (2019) Cryptococcosis with central nervous system involvement in a dog in the UK: a case report and review of the condition. Companion Animal 24:8, pages 414-418.
Crossref
Jacqueline G. Gerhart, Kevin M. Watt, Andrea Edginton, Kelly C. Wade, Sara N. Salerno, Daniel K. BenjaminJrJr, P. Brian Smith, Christoph P. Hornik, Michael Cohen‐Wolkowiez, Shahnaz Duara, Ashley Ross, Karen Shattuck, Dan L. Stewart, Natalie Neu, Daniel Gonzalez, Gary Furda, Danny Benjamin, Edmund Capparelli, Gregory L. Kearns, Ian M. Paul, Jan Sullivan & Kelly Wade. (2019) Physiologically‐Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants. CPT: Pharmacometrics & Systems Pharmacology 8:7, pages 500-510.
Crossref
Beatrice L Colon, Christopher A Rice, R Kiplin Guy & Dennis E Kyle. (2019) Phenotypic Screens Reveal Posaconazole as a Rapidly Acting Amebicidal Combination Partner for Treatment of Primary Amoebic Meningoencephalitis. The Journal of Infectious Diseases 219:7, pages 1095-1103.
Crossref
Divine C Nwafor, Allison L Brichacek, Afroz S Mohammad, Jessica Griffith, Brandon P Lucke-Wold, Stanley A Benkovic, Werner J Geldenhuys, Paul R Lockman & Candice M Brown. (2019) Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment. Journal of Central Nervous System Disease 11, pages 117957351984065.
Crossref
Gerardo Alvarez-Uria, Manoranjan Midde, Jayaram Battula & Himachandra N.B. Pujari. (2018) Safety and tolerability of intrathecal liposomal amphotericin B ( AmBisome ) for cryptococcal meningitis: a retrospective study in HIV-infected patients . Therapeutic Advances in Infectious Disease 5:5, pages 77-81.
Crossref
Katharine E. Stott, Justin Beardsley, Ruwanthi Kolamunnage-Dona, Anahi Santoyo Castelazo, Freddie Mukasa Kibengo, Nguyen Thi Hoang Mai, Nguyễn Lê Nhu’ Tùng, Ngo Thi Kim Cuc, Jeremy Day & William Hope. (2018) Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis. Antimicrobial Agents and Chemotherapy 62:9.
Crossref
Jeremy S. Nel, Luther A. Bartelt, David van Duin & Anne M. Lachiewicz. (2018) Endemic Mycoses in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America 32:3, pages 667-685.
Crossref
Justin Beardsley, Catriona L Halliday, Sharon C-A Chen & Tania C Sorrell. (2018) Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside. Future Microbiology 13:10, pages 1175-1191.
Crossref
Katharine E. Stott, Justin Beardsley, Sarah Whalley, Freddie Mukasa Kibengo, Nguyen Thi Hoang Mai, Nguyễn Lê Nhu' Tùng, Ngo Thi Kim Cuc, Ruwanthi Kolamunnage-Dona, William Hope & Jeremy Day. (2018) Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis. Antimicrobial Agents and Chemotherapy 62:7.
Crossref
Izabel Almeida Alves, Keli Jaqueline Staudt, Fernando Olinto Carreño, Graziela de Araujo Lock, Carolina de Miranda Silva, Stela Maris Kuze Rates, Teresa Dalla Costa & Bibiana Verlindo De Araujo. (2018) Population Pharmacokinetic Modeling to Describe the Total Plasma and Free Brain Levels of Fluconazole in Healthy and Cryptococcus neoformans Infected Rats: How Does the Infection Impact the Drug’s Levels on Biophase?. Pharmaceutical Research 35:7.
Crossref
Hassan Shah, Stephen Honeybul, Stephanie Tang, Ian Arthur, Sally McLaren & Peter Boan. (2018) Mould meningitis associated with intravenous drug use. Medical Mycology Case Reports 20, pages 18-20.
Crossref
Fernanda Wirth, Maria Isabel de Azevedo, Carmen Pilla, Valério Rodrigues Aquino, Gustavo Wissmann Neto & Luciano Zubaran Goldani. (2018) Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis. Medical Mycology 56:3, pages 257-262.
Crossref
Anjan Debnath, Claudia M. Calvet, Gareth Jennings, Wenxu Zhou, Alexander Aksenov, Madeline R. Luth, Ruben Abagyan, W. David Nes, James H. McKerrow & Larissa M. Podust. (2017) CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM). PLOS Neglected Tropical Diseases 11:12, pages e0006104.
Crossref
Anne-Hortense Schmitt-Hoffmann, Kota Kato, Robert Townsend, Michael J. Potchoiba, William W. Hope, David Andes, Jochen Spickermann & Marlowe J. Schneidkraut. (2017) Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats. Antimicrobial Agents and Chemotherapy 61:12.
Crossref
Mihai Puia-Dumitrescu & P. Brian Smith. (2017) Antifungal Drugs in Newborns and Children. Pediatric Clinics of North America 64:6, pages 1389-1402.
Crossref
Wei Wang, Na Zheng, Jiatang Zhang, Xusheng Huang & Shengyuan Yu. (2017) Effect of Efflux Transporter Inhibition on the Distribution of Fluconazole in the Rat Brain. Neurochemical Research 42:8, pages 2274-2281.
Crossref
Prasan Kumar Panda, Sunil Kumar Mavidi, Naveet Wig, Ajay Garg, Aasma Nalwa & M. C. Sharma. (2017) Intracranial Aspergillosis in an Immunocompetent Young Woman. Mycopathologia 182:5-6, pages 527-538.
Crossref
Sudarshan Singh Rathore, Aishwarya Mathivanan, Abirami Ravindran, Ponnusami Venkatacha & Jayapradha Ramakrishn. (2017) Potential Anticryptococcal Compound from Marine Nocardiopsis synnemataformans. Journal of Biological Sciences 17:4, pages 157-170.
Crossref
Sérgio Monteiro de Almeida & Thiago Henrique Roza. (2016) HIV Immune Recovery Inflammatory Syndrome and Central Nervous System Paracoccidioidomycosis. Mycopathologia 182:3-4, pages 393-396.
Crossref
Javier M. Gonzalez, Carlos A. Rodriguez, Maria Agudelo, Andres F. Zuluaga & Omar Vesga. (2017) Antifungal pharmacodynamics: Latin America's perspective. The Brazilian Journal of Infectious Diseases 21:1, pages 79-87.
Crossref
Beatriz Bustamante, Jose A. Hidalgo & Pablo E. Campos. 2017. Current Progress in Medical Mycology. Current Progress in Medical Mycology 29 89 .
George R. ThompsonIIIIII, Adrian Rendon, Rodrigo Ribeiro dos Santos, Flavio Queiroz-Telles, Luis Ostrosky-Zeichner, Nkechi Azie, Rochelle Maher, Misun Lee, Laura Kovanda, Marc Engelhardt, Jose A. Vazquez, Oliver A. Cornely & John R. Perfect. (2016) Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses. Clinical Infectious Diseases 63:3, pages 356-362.
Crossref
Kristin Shirey, Kayla R. Stover, John Cleary, Ngoc Hoang & Jonathan Hosler. (2016) Membrane-Anchored Cyclic Peptides as Effectors of Mitochondrial Oxidative Phosphorylation. Biochemistry 55:14, pages 2100-2111.
Crossref
Peter G. Pappas, Carol A. Kauffman, David R. Andes, Cornelius J. Clancy, Kieren A. Marr, Luis Ostrosky-Zeichner, Annette C. Reboli, Mindy G. Schuster, Jose A. Vazquez, Thomas J. Walsh, Theoklis E. Zaoutis & Jack D. Sobel. (2016) Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 62:4, pages e1-e50.
Crossref
D.L. da Silva, T.F.F. Magalhães, J.R.A. dos Santos, T.P. de Paula, L.V. Modolo, A. de Fátima, C.V. Buzanello Martins, D.A. Santos & M.A. de Resende-Stoianoff. (2016) Curcumin enhances the activity of fluconazole against Cryptococcus gattii -induced cryptococcosis infection in mice . Journal of Applied Microbiology 120:1, pages 41-48.
Crossref
Muzaffar Iqbal, Essam Ezzeldin, Mashooq A. Bhat, Mohammad Raish & Khalid A. Al-Rashood. (2016) Preclinical pharmacokinetics, tissue distribution and excretion studies of a novel anti-candidal agent-thiosemicarbazide derivative of isoniazid (TSC-INH) by validated UPLC–MS/MS assay. Journal of Pharmaceutical and Biomedical Analysis 117, pages 109-117.
Crossref
Kallol Dutta, Sourish Ghosh & Anirban Basu. 2016. Inflammation: the Common Link in Brain Pathologies. Inflammation: the Common Link in Brain Pathologies 71 138 .
Nicolette R. Holt & Karin A. Thursky. 2016. Drug Dosing in Obesity. Drug Dosing in Obesity 77 96 .
Liang Huang, Hui Ye, Junyan Qu, Yanbin Liu, Cejun Zhong, Guangmin Tang, Ying Liu, Yao Huang & Xiaoju Lv. (2015) Analysis of cerebrospinal fluid protein concentrations of patients with cryptococcal meningitis treated with antifungal agents. BMC Infectious Diseases 15:1.
Crossref
Kevin Kiyoshi Noguchi, Omar Hoseá Cabrera, Brant S. Swiney, Patricia Salinas-Contreras, Julie Kathryn Smith & Nuri B. Farber. (2015) Hedgehog regulates cerebellar progenitor cell and medulloblastoma apoptosis. Neurobiology of Disease 83, pages 35-43.
Crossref
J. D. Lemetayer, P. M. Dowling, S. M. Taylor & M. G. Papich. (2015) Pharmacokinetics and distribution of voriconazole in body fluids of dogs after repeated oral dosing. Journal of Veterinary Pharmacology and Therapeutics 38:5, pages 451-456.
Crossref
Paul E. Verweij, Michelle Ananda-Rajah, David Andes, Maiken C. Arendrup, Roger J. Brüggemann, Anuradha Chowdhary, Oliver A. Cornely, David W. Denning, Andreas H. Groll, Koichi Izumikawa, Bart Jan Kullberg, Katrien Lagrou, Johan Maertens, Jacques F. Meis, Pippa Newton, Iain Page, Seyedmojtaba Seyedmousavi, Donald C. Sheppard, Claudio Viscoli, Adilia Warris & J. Peter Donnelly. (2015) International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resistance Updates 21-22, pages 30-40.
Crossref
Nicole R. Zane & Dhiren R. Thakker. (2014) A Physiologically Based Pharmacokinetic Model for Voriconazole Disposition Predicts Intestinal First-pass Metabolism in Children. Clinical Pharmacokinetics 53:12, pages 1171-1182.
Crossref
Ji-Qin Wu, Kun Shao, Xuan Wang, Rui-Ying Wang, Ya-Hui Cao, Yun-Qiu Yu, Jin-Ning Lou, Yan-Qiong Chen, Hua-Zhen Zhao, Qiang-Qiang Zhang, Xin-Hua Weng, Chen Jiang & Li-Ping Zhu. (2014) In Vitro and In Vivo Evidence for Amphotericin B as a P-Glycoprotein Substrate on the Blood-Brain Barrier . Antimicrobial Agents and Chemotherapy 58:8, pages 4464-4469.
Crossref
Herbert Spapen, Jerrold Spapen, Fabio S. Taccone, Wouter Meersseman, Jordi Rello, George Dimopoulos, Pierre-Emmanuel Charles, Ratna Rao, Marcos Pérez, Claude Martin, Dirk Vogelaers & Stijn I. Blot. (2014) Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort. International Journal of Antimicrobial Agents 43:2, pages 165-169.
Crossref
Mario León Silva-Vergara, Ivonete Helena Rocha, Rakel Rocha Vasconcelos, André Luiz Maltos, Fernando de Freitas Neves, Luciana de Almeida Silva Teixeira & Delio José Mora. (2014) Central Nervous System Paracoccidioidomycosis in an AIDS Patient: Case Report. Mycopathologia 177:1-2, pages 137-141.
Crossref
Timothy Felton, Peter F. Troke & William W. Hope. (2014) Tissue Penetration of Antifungal Agents. Clinical Microbiology Reviews 27:1, pages 68-88.
Crossref
Pierluigi Brazzola & Mario R. Rossi. (2014) High weekly doses of liposomal amphotericin B as secondary prophylaxis after cerebral aspergillosis in a paediatric patient. Medical Mycology Case Reports 3, pages 1-3.
Crossref
J.M.K. Murthy & C. Sundaram. 2014. Neurologic Aspects of Systemic Disease Part III. Neurologic Aspects of Systemic Disease Part III 1383 1401 .
Katharina M. Busl & Thomas P. Bleck. (2013) Bacterial Infections of the Central Nervous System. Current Infectious Disease Reports 15:6, pages 612-630.
Crossref
Michael E. Henry, Nicolas R. Bolo, Chun S. Zuo, Rosemond A. Villafuerte, Kenroy Cayetano, Paul Glue, Bharat D. Damle, Emma Andrews, Tara L. Lauriat, Namoode S. Rana, Jeffrey H. Churchill & Perry F. Renshaw. (2013) Quantification of Brain Voriconazole Levels in Healthy Adults Using Fluorine Magnetic Resonance Spectroscopy. Antimicrobial Agents and Chemotherapy 57:11, pages 5271-5276.
Crossref
Anand Veeravagu, Cassie Ludwig, Joaquin Q. Camara-Quintana, Bowen Jiang, Nandan Lad & Lawrence Shuer. (2013) Fungal Infection of a Ventriculoperitoneal Shunt: Histoplasmosis Diagnosis and Treatment. World Neurosurgery 80:1-2, pages 222.e5-222.e13.
Crossref
Xiang-Wei Zhu, Alexander Sedykh, Hao Zhu, Shu-Shen Liu & Alexander Tropsha. (2013) The Use of Pseudo-Equilibrium Constant Affords Improved QSAR Models of Human Plasma Protein Binding. Pharmaceutical Research 30:7, pages 1790-1798.
Crossref
Anabela Malho Guedes, Teresa Anastácio de Macedo, Carla Rocha, José Neves & Joana Mapril. (2013) Early Fungal Infection in an Aortic Prosthesis with Probable Cerebral Metastasis: The Success of a Conservative Strategy. Clinical Drug Investigation 33:S1, pages 41-45.
Crossref
Alexander V. LyubimovGillian C. Wallace, Diane B. Ramsden & M. Helen Grant. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 47 .
Stefan Schwartz. (2012) Bildgebende Diagnostikverfahren und Therapieoptionen bei zerebralen Aspergillosen. Mycoses 55, pages 10-16.
Crossref
Edward Stenehjem & Wendy S. Armstrong. (2012) Central Nervous System Device Infections. Infectious Disease Clinics of North America 26:1, pages 89-110.
Crossref
Hosam A. Mousselli & John Norwood. (2012) Failure of Echinocandin Therapy in the Treatment of Candida glabrata Chorioretinitis. The American Journal of the Medical Sciences 343:1, pages 98-100.
Crossref
C. Sundaram & J. M. K. Murthy. (2011) Intracranial Aspergillus Granuloma . Pathology Research International 2011, pages 1-5.
Crossref
S. Schwartz, A. Reisman & P. F. Troke. (2011) The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection 39:3, pages 201-210.
Crossref
Deirdre O’Brien, Niall T. Stevens, Chor Hiang Lim, Donncha F. O’Brien, Edmond Smyth, Fidelma Fitzpatrick & Hilary Humphreys. (2011) Candida infection of the central nervous system following neurosurgery: a 12-year review. Acta Neurochirurgica 153:6, pages 1347-1350.
Crossref
K. Robson & P. M. Smith. (2011) Cryptococcal meningoencephalitis in a dog. Veterinary Record 168:20, pages 538-538.
Crossref
Alexander Lepak & David Andes. (2011) Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting. Critical Care Clinics 27:1, pages 123-147.
Crossref
David R. Andes & Alex J. Lepak. 2011. Essentials of Clinical Mycology. Essentials of Clinical Mycology 121 134 .
Sanjay G. Revankar & Deanna A. Sutton. (2010) Melanized Fungi in Human Disease. Clinical Microbiology Reviews 23:4, pages 884-928.
Crossref
Roland Nau, Fritz Sörgel & Helmut Eiffert. (2010) Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections. Clinical Microbiology Reviews 23:4, pages 858-883.
Crossref
W Manosuthi, P Chetchotisakd, TL Nolen, D Wallace, S Sungkanuparph, T Anekthananon, K Supparatpinyo, PG Pappas, RA Larsen, SG Filler & D Andes. (2010) Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV‐associated cryptococcal meningitis‐infected patients. HIV Medicine 11:4, pages 276-281.
Crossref
V. Staedtke, M. Brähler, A. Müller, R. Georgieva, S. Bauer, N. Sternberg, A. Voigt, A. Lemke, C. Keck, J. Möschwitzer & H. Bäumler. (2010) In vitro Inhibition of Fungal Activity by Macrophage-Mediated Sequestration and Release of Encapsulated Amphotericin B Nanosupension in Red Blood Cells. Small 6:1, pages 96-103.
Crossref
Stefan Schwartz. 2010. Aspergillosis: From Diagnosis to Prevention. Aspergillosis: From Diagnosis to Prevention 835 852 .
Wendy C. Ziai & John J. LewinIIIIII. (2008) Update in the Diagnosis and Management of Central Nervous System Infections. Neurologic Clinics 26:2, pages 427-468.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.